42% of early RA patients in Canadian CATCH cohort had prior inflamm joint palindromic-type symptoms (that ‘come and go’) and this subgroup had some interesting associations... #EULAR2019 FRI0065 @RheumNow @Janetbirdope https://t.co/tcjzObIfsB

Is there added value of antiCarP for RA dx? THU0139. Think of ACPA as citrullination vs CarP -carbamyllation Don't know if added value for dx but CarP equally + at nearly half in ACPA + &- so could it replace ACPA and use it with RF #EULAR2019 @RheumNow https://t.co/M7PfRysLel

Biosimilar interchangeability: different strokes for different folks... Gerd Burmester at #EULAR2019 @RheumNow https://t.co/JeZVzyvIZQ

Older age of onset of sjogren's has more sicca than younger and older slightly less antibodies in a large group of Sjogrens pts from many countries. Also older mean age of onset than previous yrs like RA found #EULAR2019 @RheumNow abs THU0277 https://t.co/bRMVtyYCkJ

Reade Amsterdam Gout study of 75 gout (many polyarticular) found neutrophil extracellular traps or NETS are increased in #gout patients and NETS correlate with cardiovascular risk. #Eular2019 OP0300 https://t.co/ZVeL9ltF7B

7/72 pts treated with PD-1 inh monotherapy developed de novo inflamm arthritis irAEs confirmed on USS (three PD, four greyscale synovitis). More and more centers reporting >5% inflamm arthritis irAEs - its presence is underestimated! #EULAR2019 THU0035 Sapienza, Rome @RheumNow https://t.co/zWpUtEAEMa

Dr. van der Heijde presents results of dual neutralization of Il-17A and F with bimekizumab which may provide a new therapeutic option for patients with AxSpA. Abstract OPO231. #EULAR2019 @RheumNow #spondylitis https://t.co/caOkc47jyn

Dr. Xenofon Baraliakos presents the MAXIMISE trial which showed improvement in axial involvement in PsA patients treated with secukinumab. Abstract OPO235 #EULAR2019 @RheumNow #spondylitis #Novartis https://t.co/exxbgIxgJT

No increase in immunogenicity after switching (1 or more) from originator IFX to biosimilars in pts with #RheumatoidArthritis according to a prospective study by Lauret et al. #EULAR2019 @RheumNow #Rheumatology https://t.co/SB89O1Kdc2

GCA patients have decreased proportions of PD1+CD4+ Th cells compared to normal controls, building on previous Weyand lab work. Once again, irAEs and PMR/GCA might be friends? #EULAR2019 FRI0266 Hid Cadena from Elisabeth Brouwer’s group @RheumNow https://t.co/H6bhO1jH2S

Mayo RCT on Flares in established RA randomized 150 pts to usual care or a flare (pt self declared) survey scheme found pts flaring prefer self management 62% over expedited clinic visit 32%, but intervention was no better than usual care! OP0309 #Eular2019 https://t.co/zGlW43ppqi